The deal was announced in early November, and most analyst notes so far focus on pricing, eligibility, and timelines rather than revised line-item revenue forecasts
PMID: 32730231
Using the 2.5 million estimate to be conservative, that works out to 550,000 people with OUD receiving indicated OUD treatment and 174,000 people with OUD being incidentally treated on GLP-1s
Check total and free testosterone, SHBG, and fasting insulin every 36 months
However, some of these medications have also been approved as weight-loss drugs
How the Hims model handles a semaglutide prescription Hims (Hims & Hers Health) runs as subscription telehealth: an intake covering weight, medical history, and current medications